Viewing Study NCT06939127


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-03-03 @ 2:48 AM
Study NCT ID: NCT06939127
Status: RECRUITING
Last Update Posted: 2025-04-22
First Post: 2025-04-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC
Sponsor:
Organization: